News Analysis
The COVID-19 coronavirus supply chain disruption has exposed the existential healthcare risk from China manufacturing 80 percent of medications consumed in the United States.
Precarious Risk From China Producing 80 Percent of US Medications
Save
An employee works on the production line of a herbal medicine company in Bozhou City, Anhui Province, China, on April 8, 2013. VCG via Getty Images
Updated:
